Device type · MTG
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MTG
Immunology
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
13
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
- Product code
- MTG
- Device class
- Class III
- Review panel
- Immunology
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for MTG
Latest FDA decisions
Siemens Healthcare Diagnostics, Inc.
P250026 · Decided May 11, 2026 · 297 days after receipt
Device type: Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions (MTG) · Laboratory Medicine & Pathology
Reports received
13
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
13
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 1 | 0 | 0 | 0 |
| Apr 24 | 1 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 1 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 1 | 0 | 0 | 0 |
| May 25 | 3 | 0 | 0 | 0 |
| Jun 25 | 2 | 0 | 0 | 0 |
| Jul 25 | 3 | 0 | 0 | 0 |
| Aug 25 | 3 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 2 | 0 | 0 | 0 |
| Nov 25 | 2 | 0 | 0 | 0 |
| Dec 25 | 2 | 0 | 0 | 0 |
| Jan 26 | 1 | 0 | 0 | 0 |
| Feb 26 | 2 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 2 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 | 0 |
| Sep 26 | 1 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Incorrect Measurement10
- Low Test Results4
- High Test Results3
3 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions13
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- ABBOTT DIAGNOSTICS ALINITY I FREE PSA US(200TEST/EA) REAGENT.Open, Classified
Mckesson Medical-Surgical Inc. Corporate Office
Z-1852-2025 · Started Apr 24, 2025 · Posted by FDA May 27, 2025
Reason given: transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.
Cause as FDA categorized it: Storage
Z-1645-2012 · Started Oct 11, 2011 · Posted by FDA May 22, 2012
Reason given: A recall was initiated because Beckman Coulter has confirmed a change to the recommended diluents for the Access Hybritech free PSA reagent.
Cause as FDA categorized it: Process design
Z-2220-2009 · Started Jan 8, 2008 · Posted by FDA Sep 16, 2009
Reason given: Beckman Coulter incorrectly shipped Access Hybritech free PSA calibrators containing dual calibration cards (Hybritech and WHO) to your lab. The WHO calibration for free PSA is marketed without a PMA.
Cause as FDA categorized it: Other
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.